Statin Intolerance, Anti‐HMGCR Antibodies, and Immune Checkpoint Inhibitor‐Associated Myositis: A “Two‐Hit” Autoimmune Toxicity or Clinical Predisposition?

Immune‐related adverse events induced by immune checkpoint inhibitor (ICI) therapy may affect diverse organ systems, including skeletal and cardiac muscle. ICI‐associated myositis may result in substantial morbidity and occasional mortality. We present a case of a patient with advanced non‐small cel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: von Itzstein, Mitchell S., Khan, Shaheen, Popat, Vinita, Lu, Rong, Khan, Saad A., Fattah, Farjana J., Park, Jason Y., Bermas, Bonnie L., Karp, David R., Ahmed, Murtaza, Saltarski, Jessica M., Gloria‐McCutchen, Yvonne, Xie, Yang, Li, Quan‐Zhen, Wakeland, Edward K., Gerber, David E.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Brief Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7418340/
https://ncbi.nlm.nih.gov/pubmed/32400023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0911
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados